Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# $sgmo

FDA grants Fast Track designation for ST-503, boosting hopes for pain and Fabry disease treatments. Investors anticipate potential partnerships and positive clinical data, driving significant social media buzz.

### About $sgmo
SGMO is a biotechnology company focused on genomic medicine.  

### Insights
- $sgmo engagements is up XXXXX% from the previous week.

### Engagements: XXXXXX (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$sgmo/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$sgmo/time-series/interactions.tsv)  
Current Value: XXXXXX  
Daily Average: XXXXXX  
X Week: XXXXXX +25%  
X Month: XXXXXXX -XX%  
X Months: XXXXXXXXX -XX%  
X Year: XXXXXXXXXX +66%  
1-Year High: XXXXXXX on 2024-12-31  
1-Year Low: XXXXX on 2025-12-06  

Engagements by network (24h):
X: XXXXXX
YouTube: X

  
  
### Mentions: XXX (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$sgmo/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$sgmo/time-series/posts_active.tsv)  
Current Value: XXX  
Daily Average: XXX  
X Week: XXX -XX%  
X Month: XXXXX +68%  
X Months: XXXXX -XX%  
X Year: XXXXXX +150%  
1-Year High: XXX on 2025-01-02  
1-Year Low: XX on 2025-05-25  

Mentions by network (24h):
X: XXXXX
YouTube: X

  
  
### Creators: XXX (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$sgmo/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$sgmo/time-series/contributors_active.tsv)  
XXX unique social accounts have posts mentioning $sgmo in the last XX hours which is up XXX% from XX in the previous XX hours
Daily Average: XX  
X Week: XXX -XX%  
X Month: XXX +188%  
X Months: XXXXX +169%  
X Year: XXXXX +162%  
1-Year High: XXX on 2025-06-29  
1-Year Low: XX on 2025-05-25  

The most influential creators that mention $sgmo in the last XX hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@BiotechAnalysst](/creator/twitter/BiotechAnalysst) | X    | XXXXX     | XX    | XXXXX       |
| [@yusufhameed](/creator/twitter/yusufhameed)         | X    | XXXXX     | XX    | XXXXX       |
| [@Franca_ole](/creator/twitter/Franca_ole)           | X    | XXX       | XX    | XXXXX       |
| [@bulpro95856](/creator/twitter/bulpro95856)         | X    | XX        | X     | XXXXX       |
| [@ParadiseTraderr](/creator/twitter/ParadiseTraderr) | X    | XXX       | X     | XXX         |
| [@AnthonyLew81615](/creator/twitter/AnthonyLew81615) | X    | XX        | X     | XXX         |
| [@truthdotphd](/creator/twitter/truthdotphd)         | X    | XXXXX     | X     | XXX         |
| [@Corona_N_Lyme](/creator/twitter/Corona_N_Lyme)     | X    | XXXXX     | X     | XXX         |
| [@lucas_gs05](/creator/twitter/lucas_gs05)           | X    | XXXXX     | X     | XXX         |
| [@blackswantrader](/creator/twitter/blackswantrader) | XX   | XXX       | X     | XXX         |

[View More](/list/creators/$sgmo/100)
  
  
### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$sgmo/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$sgmo/time-series/sentiment.tsv)  
Current Value: XX%  
Daily Average: XX%  
X Week: XX% -X%  
X Month: XX% -XX%  
X Months: XX% -X%  
X Year: XX% -XX%  
1-Year High: XXX% on 2025-05-19  
1-Year Low: XX% on 2025-12-06  

Most Supportive Themes:
- Upcoming Data and Positive Developments: (60%) Anticipation of upcoming clinical data presentations and potential breakthroughs are driving positive sentiment.
- Bullish Sentiment and Recommendations: (30%) Positive sentiment and recommendations from various bloggers and users are contributing to the positive outlook.
  
Most Critical Themes:
- Market Volatility and Risks: (10%) Concerns about the stock's performance and potential risks are present.
  

### Top $sgmo Social Posts
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"The next $WVE $ARWR $VTYX are in biotech. I think the best is $SGMO. Its pipelines and programs will be worth at least 10x once one of them starts to get bought. And I truly believe $SGMO will return 10x from the current depressed level to $5-$10 in 2026"  
[X Link](https://x.com/bill_us/status/1998072947131445577) [@bill_us](/creator/x/bill_us) 2025-12-08T16:51Z 2392 followers, 1613 engagements


"TOP X ACTIVE WATCHLIST FOR BOTH PORTFOLIOS Growth X. $GOOGL X. $OKLO X. $IREN X. $NBIS X. $ISRG Small-Cap X. $ONDS X. $RR X. $OSCR X. $CIFR X. $PRCT $SCPH $ADMA $BMRN $FOLD $ICPT $IONS $INTL $SGMO $CLDX $INO $KRTX $ONTX $ARVN $MGNX $EIGR $SPR $NVAX $SRPT $ABEO $ANVS $BCEL"  
[X Link](https://x.com/ParadiseTraderr/status/1998042499248693329) [@ParadiseTraderr](/creator/x/ParadiseTraderr) 2025-12-08T14:50Z XXX followers, XXX engagements


"$PFE $SGMO Sangamo's gene therapy showed strong Phase X data (superior to standard prophylaxis with durable FVIII expression) potentially offering a more transformative one-and-done alternative for hemophilia A patients without inhibitors. However it's not "better" in practice yetHympavzi is approved accessible and addresses a wider population (including inhibitors and hemophilia B) while gene therapies like giroctocogene face commercialization headwinds (e.g. patient/physician hesitancy high costs and Pfizer's pivot to non-gene options like Hympavzi). Sangamo is optimistic about partnering"  
[X Link](https://x.com/yusufhameed/status/1998005298066251930) [@yusufhameed](/creator/x/yusufhameed) 2025-12-08T12:22Z 1752 followers, 2664 engagements


"@UnionSteel2017 Leme put it this way Once they resolve their cash problem (which i think they wil) Then market will rerate $sgmo based on their platform IMO next year will be big for them"  
[X Link](https://x.com/Jota5571189851/status/1997998698077282718) [@Jota5571189851](/creator/x/Jota5571189851) 2025-12-08T11:56Z X followers, XXX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

$sgmo

FDA grants Fast Track designation for ST-503, boosting hopes for pain and Fabry disease treatments. Investors anticipate potential partnerships and positive clinical data, driving significant social media buzz.

About $sgmo

SGMO is a biotechnology company focused on genomic medicine.

Insights

  • $sgmo engagements is up XXXXX% from the previous week.

Engagements: XXXXXX (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXXX
Daily Average: XXXXXX
X Week: XXXXXX +25%
X Month: XXXXXXX -XX%
X Months: XXXXXXXXX -XX%
X Year: XXXXXXXXXX +66%
1-Year High: XXXXXXX on 2024-12-31
1-Year Low: XXXXX on 2025-12-06

Engagements by network (24h): X: XXXXXX YouTube: X

Mentions: XXX (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXX
X Week: XXX -XX%
X Month: XXXXX +68%
X Months: XXXXX -XX%
X Year: XXXXXX +150%
1-Year High: XXX on 2025-01-02
1-Year Low: XX on 2025-05-25

Mentions by network (24h): X: XXXXX YouTube: X

Creators: XXX (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
XXX unique social accounts have posts mentioning $sgmo in the last XX hours which is up XXX% from XX in the previous XX hours Daily Average: XX
X Week: XXX -XX%
X Month: XXX +188%
X Months: XXXXX +169%
X Year: XXXXX +162%
1-Year High: XXX on 2025-06-29
1-Year Low: XX on 2025-05-25

The most influential creators that mention $sgmo in the last XX hours

Creator Rank Followers Posts Engagements
@BiotechAnalysst X XXXXX XX XXXXX
@yusufhameed X XXXXX XX XXXXX
@Franca_ole X XXX XX XXXXX
@bulpro95856 X XX X XXXXX
@ParadiseTraderr X XXX X XXX
@AnthonyLew81615 X XX X XXX
@truthdotphd X XXXXX X XXX
@Corona_N_Lyme X XXXXX X XXX
@lucas_gs05 X XXXXX X XXX
@blackswantrader XX XXX X XXX

View More

Sentiment: XX%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XX% -X%
X Month: XX% -XX%
X Months: XX% -X%
X Year: XX% -XX%
1-Year High: XXX% on 2025-05-19
1-Year Low: XX% on 2025-12-06

Most Supportive Themes:

  • Upcoming Data and Positive Developments: (60%) Anticipation of upcoming clinical data presentations and potential breakthroughs are driving positive sentiment.
  • Bullish Sentiment and Recommendations: (30%) Positive sentiment and recommendations from various bloggers and users are contributing to the positive outlook.

Most Critical Themes:

  • Market Volatility and Risks: (10%) Concerns about the stock's performance and potential risks are present.

Top $sgmo Social Posts

Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"The next $WVE $ARWR $VTYX are in biotech. I think the best is $SGMO. Its pipelines and programs will be worth at least 10x once one of them starts to get bought. And I truly believe $SGMO will return 10x from the current depressed level to $5-$10 in 2026"
X Link @bill_us 2025-12-08T16:51Z 2392 followers, 1613 engagements

"TOP X ACTIVE WATCHLIST FOR BOTH PORTFOLIOS Growth X. $GOOGL X. $OKLO X. $IREN X. $NBIS X. $ISRG Small-Cap X. $ONDS X. $RR X. $OSCR X. $CIFR X. $PRCT $SCPH $ADMA $BMRN $FOLD $ICPT $IONS $INTL $SGMO $CLDX $INO $KRTX $ONTX $ARVN $MGNX $EIGR $SPR $NVAX $SRPT $ABEO $ANVS $BCEL"
X Link @ParadiseTraderr 2025-12-08T14:50Z XXX followers, XXX engagements

"$PFE $SGMO Sangamo's gene therapy showed strong Phase X data (superior to standard prophylaxis with durable FVIII expression) potentially offering a more transformative one-and-done alternative for hemophilia A patients without inhibitors. However it's not "better" in practice yetHympavzi is approved accessible and addresses a wider population (including inhibitors and hemophilia B) while gene therapies like giroctocogene face commercialization headwinds (e.g. patient/physician hesitancy high costs and Pfizer's pivot to non-gene options like Hympavzi). Sangamo is optimistic about partnering"
X Link @yusufhameed 2025-12-08T12:22Z 1752 followers, 2664 engagements

"@UnionSteel2017 Leme put it this way Once they resolve their cash problem (which i think they wil) Then market will rerate $sgmo based on their platform IMO next year will be big for them"
X Link @Jota5571189851 2025-12-08T11:56Z X followers, XXX engagements

$sgmo
/topic/$sgmo